TECH – Bio-Techne Corporation
Bio-Techne CorpTECH
$64.92Name : Bio-Techne Corp
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,263,072,768.00
EPSttm : 0.98
Bio-Techne Corp
$64.92
0.87%$0.57Float Short %
2.53
Margin Of Safety %
58
Put/Call OI Ratio
0.18
EPS Next Q Diff
0.13
EPS Last/This Y
EPS This/Next Y
0.3
Price
64.94
Target Price
85.75
Analyst Recom
1.82
Performance Q
-2.9
Relative Volume
1.87
Beta
1.27
Ticker: TECH
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | TECH | 76.91 | 0.10 | 0.02 | 2042 |
| 2025-01-24 | TECH | 77.01 | 0.10 | 12.88 | 2073 |
| 2025-01-27 | TECH | 76.41 | 0.28 | 100.80 | 2442 |
| 2025-01-28 | TECH | 75.28 | 0.54 | 0.33 | 2941 |
| 2025-01-29 | TECH | 71.82 | 0.54 | 2.73 | 2941 |
| 2025-01-30 | TECH | 72.81 | 0.51 | 0.22 | 2910 |
| 2025-01-31 | TECH | 73.56 | 0.51 | 0.70 | 2914 |
| 2025-02-03 | TECH | 72.06 | 0.53 | 4.40 | 3077 |
| 2025-02-04 | TECH | 72.63 | 0.54 | 21.97 | 3097 |
| 2025-02-05 | TECH | 75.25 | 0.33 | 0.04 | 2699 |
| 2025-02-06 | TECH | 75.04 | 0.33 | 0.07 | 2695 |
| 2025-02-07 | TECH | 72.82 | 0.33 | 0.15 | 2693 |
| 2025-02-10 | TECH | 70.56 | 0.33 | 0.20 | 2695 |
| 2025-02-11 | TECH | 68.32 | 0.33 | 1.37 | 2724 |
| 2025-02-12 | TECH | 67.38 | 0.34 | 0.67 | 2768 |
| 2025-02-13 | TECH | 66.5 | 0.34 | 0.55 | 2771 |
| 2025-02-14 | TECH | 65.94 | 0.34 | 0.08 | 2779 |
| 2025-02-18 | TECH | 65.25 | 0.33 | 0.05 | 2762 |
| 2025-02-19 | TECH | 65.78 | 0.30 | 0.03 | 2635 |
| 2025-02-20 | TECH | 65.43 | 0.29 | 0.32 | 2635 |
| 2025-02-21 | TECH | 64.92 | 0.18 | 0.02 | 2421 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | TECH | 76.91 | -3.6 | 136.5 | 1.89 |
| 2025-01-24 | TECH | 77.01 | -3.6 | 144.5 | 1.89 |
| 2025-01-27 | TECH | 76.48 | -3.6 | 141.6 | 1.89 |
| 2025-01-28 | TECH | 74.58 | -3.6 | 136.0 | 1.89 |
| 2025-01-29 | TECH | 71.81 | -3.6 | 131.8 | 1.89 |
| 2025-01-30 | TECH | 72.76 | -3.7 | 148.3 | 1.89 |
| 2025-01-31 | TECH | 73.52 | -3.7 | 147.4 | 1.89 |
| 2025-02-03 | TECH | 72.05 | -3.7 | 137.4 | 1.89 |
| 2025-02-04 | TECH | 72.62 | -3.7 | 146.7 | 1.89 |
| 2025-02-05 | TECH | 75.25 | -3.7 | 157.7 | 1.89 |
| 2025-02-06 | TECH | 75.05 | -3.7 | 143.0 | 1.89 |
| 2025-02-07 | TECH | 72.81 | -3.7 | 134.3 | 1.90 |
| 2025-02-10 | TECH | 69.92 | -3.7 | 127.0 | 1.92 |
| 2025-02-11 | TECH | 68.34 | -3.7 | 132.7 | 1.90 |
| 2025-02-12 | TECH | 67.39 | -3.7 | 135.5 | 1.90 |
| 2025-02-13 | TECH | 66.77 | -3.7 | 136.9 | 1.90 |
| 2025-02-14 | TECH | 65.94 | -3.7 | 136.0 | 1.90 |
| 2025-02-18 | TECH | 65.28 | 6.8 | 136.8 | 1.90 |
| 2025-02-19 | TECH | 65.80 | 6.8 | 142.7 | 1.90 |
| 2025-02-20 | TECH | 65.42 | 6.8 | 138.2 | 1.90 |
| 2025-02-21 | TECH | 64.94 | 6.8 | 137.4 | 1.90 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | TECH | -0.89 | -0.90 | 2.40 |
| 2025-01-24 | TECH | -0.89 | -0.90 | 2.40 |
| 2025-01-27 | TECH | -0.89 | -0.69 | 2.40 |
| 2025-01-28 | TECH | -0.89 | -0.69 | 2.58 |
| 2025-01-29 | TECH | -0.89 | -0.69 | 2.58 |
| 2025-01-30 | TECH | -1.62 | -0.69 | 2.58 |
| 2025-01-31 | TECH | -1.62 | -0.69 | 2.58 |
| 2025-02-03 | TECH | -1.62 | -0.60 | 2.58 |
| 2025-02-04 | TECH | -1.62 | -0.60 | 2.58 |
| 2025-02-05 | TECH | -1.62 | -0.60 | 2.58 |
| 2025-02-06 | TECH | -1.62 | -0.60 | 2.58 |
| 2025-02-07 | TECH | -1.62 | -0.60 | 2.58 |
| 2025-02-10 | TECH | -1.63 | -0.12 | 2.60 |
| 2025-02-11 | TECH | -1.22 | -0.12 | 2.60 |
| 2025-02-12 | TECH | -1.22 | -0.12 | 2.54 |
| 2025-02-13 | TECH | -0.56 | -0.12 | 2.54 |
| 2025-02-14 | TECH | -0.72 | -0.12 | 2.53 |
| 2025-02-18 | TECH | -0.72 | 1.07 | 2.53 |
| 2025-02-19 | TECH | -0.83 | 1.07 | 2.53 |
| 2025-02-20 | TECH | -0.83 | 1.07 | 2.53 |
| 2025-02-21 | TECH | -0.83 | 1.07 | 2.53 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.42
Avg. EPS Est. Current Quarter
0.51
Avg. EPS Est. Next Quarter
0.55
Insider Transactions
-0.83
Institutional Transactions
1.07
Beta
1.27
Average Sales Estimate Current Quarter
317
Average Sales Estimate Next Quarter
326
Fair Value
102.79
Quality Score
91
Growth Score
87
Sentiment Score
42
Actual DrawDown %
52.2
Max Drawdown 5-Year %
-60.5
Target Price
85.75
P/E
65.98
Forward P/E
29.73
PEG
5.15
P/S
8.58
P/B
4.93
P/Free Cash Flow
40.36
EPS
0.98
Average EPS Est. Cur. Y
1.9
EPS Next Y. (Est.)
2.2
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.22
Relative Volume
1.87
Return on Equity vs Sector %
-11.6
Return on Equity vs Industry %
4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
137.4
Bio-Techne CorpSector: Healthcare
Industry: Biotechnology
Employees: 3100
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
stock quote shares TECH – Bio-Techne Corporation Stock Price stock today
news today TECH – Bio-Techne Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TECH – Bio-Techne Corporation yahoo finance google finance
stock history TECH – Bio-Techne Corporation invest stock market
stock prices TECH premarket after hours
ticker TECH fair value insiders trading